Class II MHC antigen presentation defect in neonatal monocytes is not correlated with decreased MHC-II expression

Cellular Immunology

Volumn 243, Issue 2, 2006, Pages 96-106

  Canaday, David H ^a   Chakravarti, Soma ^a,c   Srivastava, Tarun ^b   Tisch, Daniel J ^a   Cheruvu, Vinay K ^a   Smialek, Jamie ^a,c   Harding, Clifford V ^a   Ramachandra, Lakshmi ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Case Western Reserve University   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Antigen presentation; Human; MHC II; Monocytes; Neonates

Indexed keywords

HLA DR1 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYBRIDOMA CELL CULTURE; MONOCYTE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; T LYMPHOCYTE; UMBILICAL CORD;

ADULT; ANTIGEN PRESENTATION; CELL MEMBRANE; CELLS, CULTURED; FEMALE; FETAL BLOOD; GENES, MHC CLASS II; HUMANS; INFANT, NEWBORN; MONOCYTES;

MURINAE;

EID: 33947248550     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2007.01.003     Document Type: Article

References (43)

1. WHO, 2005.
2. Cole F.S. Avery's Diseases of the Newborn (1998), W.B. Saunders Company, Philadelphia
3. Lewis D.B., and Tu W. Immunologic Disorders in Infants and Children (2004), Elsevier Saunders, Philadelphia
4. Remington J.S., and Klein J.O. Current Concepts of Infections of the Fetus and Newborn Infant (2001), W.B. Saunders Co., Philadelphia
5. Ramachandra L., Chu R.S., Askew D., Noss E.H., Canaday D.H., Potter N.S., Johnsen A., Krieg A.M., Nedrud J.G., Boom W.H., and Harding C.V. Immunol. Rev. 168 (1999) 217-239
6. Harding C.V., Ramachandra L., and Wick M.J. Curr. Opin. Immunol. 15 (2003) 112-119
7. Cresswell P. Annu. Rev. Immunol. 12 (1994) 259-293
8. Harding C.V. Crit. Rev. Immunol. 16 (1996) 13-29
9. Bakke O., and Dobberstein B. Cell 63 (1990) 707-716
10. Lotteau V., Teyton L., Peleraux A., Nilsson T., Karlsson L., Schmid S.L., Quaranta V., and Peterson P.A. Nature 348 (1990) 600-605
11. Cresswell P. Cell 84 (1996) 505-507
12. Nakagawa T.Y., Brissette W.H., Lira P.D., Griffiths R.J., Petrushova N., Stock J., McNeish J.D., Eastman S.E., Howard E.D., Clarke S.R., Rosloniec E.F., Elliott E.A., and Rudensky A.Y. Immunity 10 (1999) 207-217
13. Riese R.J., Wolf P.R., Brömme D., Natkin L.R., Villadangos J.A., Ploegh H.L., and Chapman H.A. Immunity 4 (1996) 357-366
14. Shi G.P., Villadangos J.A., Dranoff G., Small C., Gu L., Haley K.J., Riese R., Ploegh H.L., and Chapman H.A. Immunity 10 (1999) 197-206
15. Denzin L.K., and Cresswell P. Cell 82 (1995) 155-165
16. Sherman M.A., Weber D.A., and Jensen P.E. Immunity 3 (1995) 197-205
17. Sloan V.S., Cameron P., Porter G., Gammon M., Amaya M., Mellins E., and Zaller D.M. Nature 375 (1995) 802-806
18. Marwitz P.A., Van Arkel-Vigna E., Rijkers G.T., and Zegers B.J. Clin. Exp. Immunol. 72 (1988) 260-266
19. Keever C.A., Abu-Hajir M., Graf W., McFadden P., Prichard P., O'Brien J., and Flomenberg N. Bone Marrow Transplant. 15 (1995) 409-419
20. Langrish C.L., Buddle J.C., Thrasher A.J., and Goldblatt D. Clin. Exp. Immunol. 128 (2002) 118-123
21. Durandy A., Brami C., and Griscelli C. Am. J. Reprod. Immunol. Microbiol. 8 (1985) 94-100
22. Stiehm E.R., Sztein M.B., Steeg P.S., Mann D., Newland C., Blaese M., and Oppenheim J.J. Clin. Immunol. Immunopathol. 30 (1984) 430-436
23. Hunt D.W., Huppertz H.I., Jiang H.J., and Petty R.E. Blood 84 (1994) 4333-4343
24. Roncarolo M.G., Bigler M., Ciuti E., Martino S., and Tovo P.A. Blood. 20 (1994) 573-585
25. Petty R.E., and Hunt D.W.C. Vaccine 16 (1998) 1378-1382
26. Kotiranta-Ainamo A., Apajasalo M., Pohjavuori M., Rautonen N., and Rautonen J. Clin. Exp. Immunol. 115 (1999) 309-314
27. Deneys V.I., Mazzon A.M., De Bruyere M., Cornu G., and Brichard B. Eur. J. Haematol. 66 (2001) 107-114
28. Birle A., Nebe C.T., and Gessler P. J. Perinatol. 23 (2003) 294-299
29. Drohan L., Harding J.J., Holm B., Cordoba-Tongson E., Dekker C.L., Holmes T., Maecker H., and Mellins E.D. Hum. Immunol. 65 (2004) 1356-1369
30. Kanakoudi-Tsakalidou F., Debonera F., Drossou-Agakidou V., Sarafidis K., Tzimouli V., Taparkou A., and Kremenopoulos G. Clin. Exp. Immunol. 123 (2001) 402-407
31. Liu E., Tu W., Law H.K., and Lau Y.L. Br. J. Haematol. 113 (2001) 240-246
32. Chilmonczyk B.A., Levin M.J., McDuffy R., and Hayward A.R. J. Immunol. 134 (1985) 4184-4188
33. Garban F., Ericson M., Roucard C., Rabian-Herzog C., Teisserenc H., Sauvanet E., Charron D., and Mooney N. Blood 87 (1996) 3970-3976
34. Borras F.E., Matthews N.C., Lowdell M.W., and Navarrete C.V. Br. J. Haematol. 113 (2001) 925-931
35. Caux C., Massacrier C., Dezutter-Dambuyant C., Vanbervliet B., Jacquet C., Schmitt D., and Banchereau J. J. Immunol. 155 (1995) 5427-5435
36. Caux C., Massacrier C., Vanbervliet B., Dubois B., Durant I., Cella M., Lanzavecchia A., and Banchereau J. Blood 90 (1997) 1458-1470
37. Sorg R.V., Kogler G., and Wernet P. Bone Marrow Transplant. 22 (1998) S52-S54
38. Sorg R.V., Kogler G., and Wernet P. Blood 93 (1999) 2302-2307
39. Canaday D.H., Gehring A., Leonard E.G., Eilertson B., Schreiber J.R., Harding C.V., and Boom W.H. J. Immunol. Methods 281 (2003) 129-142
40. Gehring A.J., Dobos K.M., Belisle J.T., Harding C.V., and Boom W.H. J. Immunol. 173 (2004) 2660-2668
41. Lakey D.L., Voladri R.K., Edwards K.M., Hager C., Samten B., Wallis R.S., Barnes P.F., and Kernodle D.S. Infect. Immun. 68 (2000) 233-238
42. Ramachandra L., Noss E.H., Boom W.H., and Harding C.V. J. Exp. Med. 194 (2001) 1421-1432
43. Robbins P.A., Evans E.L., Ding A.H., Warner N.L., and Brodsky F.M. Hum. Immunol. 18 (1987) 301-313